A case report of low-dose apatinib in the treatment of advanced triple-negative breast cancer
{{output}}
Background: The current study shows that the incidence rate of triple-negative breast cancer accounts for 10-17% of invasive ductal carcinoma of the breast. There is no specific treatment target, the age of onset is relatively sm... ...
